Skip to main content

Advertisement

SpringerLink
Log in

Rapamycin for GVHD prophylaxis - potential for severe myelotoxicity

  • Correspondence
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

References

  1. Cardenas ME, Sanfridson A, Cutler NS, Heitman J . Signal-transduction cascades as targets for therapeutic intervention by natural products Trends Biotechnol 1998 16: 427–433

    Article  CAS  Google Scholar 

  2. Blazar BR, Korngold R, Vallera DA . Recent advances in graft-versus-host disease (GVHD) prevention Immunol Rev 1997 157: 79–109

    Article  CAS  Google Scholar 

  3. Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Vallera DA . Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th2 cytotoxic cytokines J Immunol 1998 160: 5355–5365

    CAS  PubMed  Google Scholar 

  4. Halloran PF . Immunosuppressive agents in clinical trials in transplantation Am J Med Sci 1997 313: 283–288

    CAS  PubMed  Google Scholar 

  5. Wells AD, Li XC, Li Y et al. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance Nature Med 1999 5: 1303–1307

    Article  CAS  Google Scholar 

  6. Groth CG, Backman L, Morales JM et al. Sirolimus (rapamycin)-based therapy in human renal transplantation Transplantation 1999 67: 1036–1042

    Article  CAS  Google Scholar 

  7. Kaplan MJ, Ellis CN, Bata-Csorgo Z et al. Systemic toxicity following administration of sirolimus (formerly rapamycin) for psoriasis: association of capillary leak syndrome with apoptosis of lesional lymphocytes Arch Dermatol 1999 135: 553–557

    Article  CAS  Google Scholar 

  8. Forre O, Haugen M, Hassfeld WG . New treatment possibilities in rheumatoid arthritis Scand J Rheumatol 2000 29: 73–84

    Article  CAS  Google Scholar 

  9. Luo Y, Marx SO, Kiyokawa H et al. Rapamycin resistance tied to defective regulation of p27Kip1 Mol Cell Biol 1996 16: 6744–6751

    Article  CAS  Google Scholar 

  10. Hashemolhosseini S, Nagamine Y, Morley SJ et al. Rapamycin inhibition of the G1 to S transition is mediated by effects on cyclin D1 mRNA and protein stability J Biol Chem 1998 273: 14424–14429

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Haematology, LRF Centre for Adult Leukaemia, Imperial College School of Medicine, Hammersmith Campus, London, UK

    RJ Davidson, SB Marley & MY Gordon

Authors
  1. RJ Davidson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. SB Marley
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. MY Gordon
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Davidson, R., Marley, S. & Gordon, M. Rapamycin for GVHD prophylaxis - potential for severe myelotoxicity. Bone Marrow Transplant 27, 115 (2001). https://doi.org/10.1038/sj.bmt.1702745

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702745

  • Springer Nature Limited

Search

Navigation